Catalyst Wire Dossier Catalyst Wire Dossier

Phenylephrine 2.5%-Tropicamide 1% microdose ophthalmic solution

· Eyenovia Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Phenylephrine 2.5%-Tropicamide 1% microdose ophthalmic solution, covering 2022-03-18 to 2022-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation [Phase 3]

See pricing